Bayern Kapital

Overview

Bayern Kapital is a public venture capital firm that provides equity financing to innovative technology startups and scale-ups in Bavaria across sectors like life sciences, software, medical technology, materials, nanotechnology, and environmental technology. It manages around €700 million in assets through thirteen funds and has invested in over 380 companies with a total participation volume of €1.3 billion. The firm supports founders from seed to scale-up phases with investments ranging from €250,000 to €25 million, backed by government initiative.

History

Bayern Kapital was founded in 1995 on the initiative of the Bavarian government as a wholly-owned subsidiary of LfA Förderbank. It has grown to manage thirteen investment funds totaling around €700 million and invested roughly €350 million in about 300 companies initially, expanding to over 380 investments. Key milestones include closing its ScaleUp fund in July 2021 and establishing itself as one of Europe's successful public VC firms in high-tech.

Product Lines

Notable Products

• ScaleUp Fund - Closed fund focused on scale-up phase investments, closed July 2021.
• Bavarian High-Tech Seed Funds - Early-stage funds for innovative tech startups in Bavaria.
• Life Science Investments - Equity in biotech and medical technology companies.
• Software & IT Funds - Investments in software and IT sector startups.
• Materials & Nano Funds - Funding for new materials, nanotechnology, and environmental tech.

Reputation

Bayern Kapital is regarded by professionals as a reliable public VC provider in Bavaria, valued for its long-term commitment and support during challenges due to government backing. Enthusiasts note its extensive portfolio of over 380 investments and role in successful Bavarian tech exits. Criticisms are limited in sources, though as a public entity, it may face perceptions of bureaucratic processes compared to private VCs.